Another report has found that FAT1 upregulation in lung cancer enhanced transforming growth factor-β and epithelial-mesenchymal transition signaling, increased CAF abundance, reduced CD8+ T cell infiltration, and was linked to low TMB 40. This evidence concerns the gene FAT1 and lung carcinoma.